Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:SCTL Societal CDMO (SCTL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Societal CDMO Stock (NASDAQ:SCTL) 30 days 90 days 365 days Advanced Chart Remove Ads Get Societal CDMO alerts:Sign Up Key Stats Today's Range$1.09▼$1.1050-Day Range$1.06▼$1.1052-Week Range$0.26▼$1.28Volume514,600 shsAverage Volume957,342 shsMarket Capitalization$116.26 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSocietal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecules in the United States and internationally. The company provides end-to-end services, such as formulation development focusing on complex formulations, reformulation, physical characterization, and excipient compatibility; analytical methods development which offers a range of analytical testing capabilities, including product testing, ICH stability, method development and validation, chromatography and spectroscopy equipment, stability chambers, and microbial testing; and pharmaceutical manufacturing that provides milling, blending, compression, spray and rotary granulation, particle and bead coating, encapsulation, liquids, lyophilization, and sterile fill and finish services. It also offers regulatory support, including handling communications with the food and drug administration (FDA) and seek consultation and guidance for client FDA meetings and responses; and pharmaceutical packaging and logistics, as well as smaller-scale primary and secondary packaging, labeling and kitting options suited for clinical trial materials and development packaging needs across dosage forms. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.Read More… Remove Ads Receive SCTL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Societal CDMO and its competitors with MarketBeat's FREE daily newsletter. Email Address SCTL Stock News HeadlinesCoreRx, Societal CDMO, and Bend Bioscience Unite Under the Bend Bioscience Brand to Provide World Class CDMO offeringSeptember 4, 2024 | tmcnet.comCoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.April 8, 2024 | globenewswire.comTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…April 1, 2025 | Paradigm Press (Ad)CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.April 8, 2024 | businesswire.comSCTL Stock Earnings: Societal CDMO Beats Revenue for Q4 2023March 25, 2024 | investorplace.comSOCIETAL CDMO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Societal CDMO, Inc. - SCTLMarch 13, 2024 | businesswire.comOwning 36% shares,institutional owners seem interested in Societal CDMO, Inc. (NASDAQ:SCTL),March 12, 2024 | finance.yahoo.comSOCIETAL CDMO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Societal CDMO, Inc. - SCTLMarch 1, 2024 | businesswire.comSee More Headlines SCTL Stock Analysis - Frequently Asked Questions How were Societal CDMO's earnings last quarter? Societal CDMO, Inc. (NASDAQ:SCTL) released its quarterly earnings data on Friday, March, 22nd. The company reported ($0.01) earnings per share (EPS) for the quarter. The business earned $27.72 million during the quarter, compared to the consensus estimate of $25.50 million. Societal CDMO had a negative net margin of 14.03% and a negative trailing twelve-month return on equity of 23.82%. What other stocks do shareholders of Societal CDMO own? Based on aggregate information from My MarketBeat watchlists, some other companies that Societal CDMO investors own include Applied DNA Sciences (APDN), Sunworks (SUNW), Meta Platforms (META), PayPal (PYPL), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and Pfizer (PFE). Company Calendar Last Earnings3/22/2024Today3/31/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:SCTL CIK1588972 Webwww.recrocdmo.com Phone(770) 534-8239Fax484-395-2471Employees258Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,270,000.00 Net Margins-14.03% Pretax Margin-13.89% Return on Equity-23.82% Return on Assets-8.80% Debt Debt-to-Equity Ratio0.01 Current Ratio1.07 Quick Ratio0.86 Sales & Book Value Annual Sales$94.64 million Price / Sales1.23 Cash FlowN/A Price / Cash FlowN/A Book Value$0.56 per share Price / Book1.96Miscellaneous Outstanding Shares105,691,000Free Float97,658,000Market Cap$116.26 million OptionableOptionable Beta1.61 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:SCTL) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Societal CDMO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Societal CDMO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.